<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76500</article-id><article-id pub-id-type="doi">10.7554/eLife.76500</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Characterization of sequence determinants of enhancer function using natural genetic variation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-288452"><name><surname>Yang</surname><given-names>Marty G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265002"><name><surname>Ling</surname><given-names>Emi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5287-0284</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265003"><name><surname>Cowley</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-138088"><name><surname>Greenberg</surname><given-names>Michael E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-264670"><name><surname>Vierbuchen</surname><given-names>Thomas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5690-5680</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Neurobiology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Laboratory of Mammalian Cell Biology and Development</institution>, <institution>Rockefeller University, Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Developmental Biology Program</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York, NY</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-94270"><name><surname>Parker</surname><given-names>Stephen CJ</given-names></name><role>Reviewing editor</role><aff><institution>University of Michigan</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>meg@hms.harvard.edu</email> (MG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>vierbuct@mskcc.org</email> (TV);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76500</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>30</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Yang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Yang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76500-v1.pdf"/><abstract><p>Sequence variation in enhancers that control cell type-specific gene transcription contributes significantly to phenotypic variation within human populations. However, it remains difficult to predict precisely the effect of any given sequence variant on enhancer function due to the complexity of DNA sequence motifs that determine transcription factor (TF) binding to enhancers in their native genomic context. Using F<sub>1</sub>-hybrid cells derived from crosses between distantly related inbred strains of mice, we identified thousands of enhancers with allele-specific TF binding and/or activity. We find that genetic variants located within the central region of enhancers are most likely to alter TF binding and enhancer activity. We observe that the AP-1 family of TFs (Fos/Jun) are frequently required for binding of TEAD TFs and for enhancer function. However, many sequence variants outside of core motifs for AP-1 and TEAD also impact enhancer function, including sequences flanking core TF motifs and AP-1 half sites. Taken together, these data represent one of the most comprehensive assessments of allele-specific TF binding and enhancer function to date and reveal how sequence changes at enhancers alter their function across evolutionary timescales.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>T32EY00711030</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Marty G</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>T32AG000222</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Marty G</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE0946799</award-id><principal-award-recipient><name><surname>Ling</surname><given-names>Emi</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE1144152</award-id><principal-award-recipient><name><surname>Ling</surname><given-names>Emi</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01 NS115965</award-id><principal-award-recipient><name><surname>Greenberg</surname><given-names>Michael E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the National Institutes of Health and the Harvard Medical School Institutional Animal Care and Use Committee and were conducted in compliance with the relevant ethical regulations (Protocol # IS00000074-3)</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>We submitted our data to GEO, and it is now accessible via GSE193728.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Yang MG</collab><collab>Ling E</collab><collab>Cowley CJ</collab><collab>Greenberg ME</collab><collab>Vierbuchen T</collab></person-group><year iso-8601-date="2022">2022</year><source>Characterization of sequence determinants of enhancer function using natural genetic variation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE193728">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE193728</ext-link><comment>NCBI Gene Expression Omnibus, GSE193728</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Vierbuchen T</collab><collab>Ling E</collab><collab>Cowley CJ</collab><collab>Couch CH et al.</collab></person-group><year iso-8601-date="2017">2017</year><source>AP-1 transcription factors and the BAF complex mediate signal-dependent enhancer selection</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83295">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83295</ext-link><comment>GEO: GSE83295</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wouter Meuleman; John A. Stamatoyannopoulos</collab></person-group><year iso-8601-date="2019">2019</year><source>Index and biological spectrum of accessible DNA elements in the human genome</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/3838751#.YcOHmGZKhBx">https://zenodo.org/record/3838751#.YcOHmGZKhBx</ext-link><comment>https://doi.org/10.1101/822510</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-76500-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>